NIVABUPA NSE filing

Niva Bupa Health Insurance's ₹250 Cr NCDs reaffirmed 'CARE AA Stable' rating

The RealCase readLow impact Neutral

Niva Bupa Health Insurance's ₹250 crore Non-Convertible Debentures have been reaffirmed with a 'CARE AA Stable' rating by Care Ratings Limited. The company received this notification on June 22, 2026.

Why it matters

A reaffirmation of an existing credit rating typically has a low impact unless there was a significant change in the rating itself. This announcement confirms the 'Stable' outlook.

The market read

The announcement is a routine credit rating reaffirmation, which is generally neutral as it confirms the existing rating without significant changes or new developments.

Niva Bupa Health Insurance Company Limited has announced that Care Ratings Limited has reaffirmed the credit rating on the company's Non-Convertible Debentures (NCDs).

The rating assigned is ‘CARE AA Stable’ on the ₹250.00 crores worth of NCDs.

The company received the letter from Care Ratings Limited on June 22, 2026, at 08:11 P.M., detailing the reaffirmation of the rating.

Filing to action

What to do with a filing like this

Niva Bupa Health Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under credit ratings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Niva Bupa Health Insurance Company Limited. Read the original for the full detail.

View original filing